Video Experimental Relacionado
Updated: Jun 4, 2025
09:38
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
13.7K
Las maquinarias de transcripción fotoquímicamente activadas, transitorias y oscilatorias guían la modulación temporal
Jiantong Dong1, Itamar Willner1
1The Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.
Journal of the American Chemical Society
|December 31, 2024
Resumen
Los investigadores desarrollaron circuitos dinámicos de transcripción para un control preciso de la coagulación de la sangre (fibrinogénesis). Estos sistemas activados por luz permiten la modulación transitoria u oscilatoria de la trombina, ofreciendo nuevas estrategias de control temporal.
Área de la Ciencia:
- La bioquímica
- Biología molecular
- Biología sintética
Sus antecedentes:
- La maquinaria de transcripción puede ser diseñada para el control dinámico.
- El control temporal de los procesos biológicos es un desafío clave.
Objetivo del estudio:
- Introducir máquinas de transcripción activadas fotoquímicamente para el control dinámico.
- Implementar estos circuitos para la modulación temporal de la fibrinogénesis a través de la trombina.
- Para lograr un control transitorio y oscilante sobre las vías biológicas.
Principales métodos:
- Desarrollo de circuitos de transcripción desencadenados fotoquímicamente.
- Utilizando la RNasa H para la activación transitoria de la trombina.
- Diseño de maquinarias de transcripción acopladas para reacciones oscilatorias.
- Empleando el modelado cinético computacional para la predicción del comportamiento dinámico.
Principales resultados:
- Se ha demostrado la activación transitoria de la trombina para la fibrinogénesis mediante un sistema fototriggerado.
- Se estableció un circuito de transcripción oscilante que conduce a la inhibición rítmica de la trombina a través de un aptamer de antitrombina.
- Rendimiento del sistema validado en condiciones fisiológicas similares y en plasma humano.
Conclusiones:
- Los circuitos de transcripción dinámicos desencadenados fotoquímicamente ofrecen un control temporal preciso sobre los procesos biológicos.
- Estos sistemas permiten la modulación transitorio y oscilante de la actividad de la trombina, afectando la fibrinogénesis.
- Los circuitos desarrollados muestran potencial para aplicaciones en entornos que imitan las condiciones fisiológicas.
Videos de Conceptos Relacionados
01:20Extrinsic and Intrinsic Pathways of Hemostasis
5.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.3K
01:16Clot Retraction and Fibrinolysis
3.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.8K
01:30General Transcription Factors
5.2K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.2K
01:09Coagulation
4.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.6K
01:16TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K